Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
Tariffs aren't likely to weigh on growth at these companies.
Amgen To Offer Cholesterol Drug At 60% Discount - Amgen ( NASDAQ:AMGN )
Amgen Inc. ( NASDAQ:AMGN ) on Monday launched AmgenNow, a new direct-to-patient program starting with Repatha ( evolucumab ) . AMGN stock is trending lower. View the charts here.
Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know
LLY shares have jumped 16% last week as Pfizer's landmark government deal boosted investor confidence across the pharma sector.
Will Pfizer ( PFE ) Beat Estimates Again in Its Next Earnings Report?
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
This Is What Whales Are Betting On Pfizer - Pfizer ( NYSE:PFE )
Investors with a lot of money to spend have taken a bullish stance on Pfizer ( NYSE:PFE ) . We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates
Saint-Herblain ( France ) , October 6, 2025 - Valneva SE ( Nasdaq: VALN. Euronext Paris: VLA ) , a specialty vaccine company, today announced that it has entered into a debt facility for up to $500 million in non-dilutive financing with funds managed by Pharmakon Advisors, LP. An initial tranche ...
Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates
New debt facility extends repayment from Q1 2026 to Q4 2030, lowers interest rate and provides access to additional capital for future business development Company adjusts 2025 financial guidance and provides key business updates
AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week?
ABBV shares rose 6% last week as optimism swept the pharma sector after Pfizer's landmark drug-pricing deal with the Trump administration.
Zacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk
Zacks Value Trader weighs whether big pharma names like Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk are genuine bargains or value traps.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
How J&J's Innovative Medicines Segment is Poised Ahead of Q3 Results
JNJ's Innovative Medicine sales face biosimilar pressure and IRA headwinds, but growth drivers like Darzalex, Tremfya and Erleada may have ensured steady Q3 momentum.
Great News for Pfizer Stock Investors
Pharma stocks have been under pressure from the administration in 2025.
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio
Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.
3 Reasons to Buy Pfizer Stock Now
After years of underperformance, the future is looking brighter for the drugmaker.
3 Dirt Cheap Stocks to Buy in a Market Priced for Perfection
Bargains can be found even when the stock market is arguably frothy.
Can Pfizer's Stock Break This Disappointing Streak?
Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many investors.
Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks.
These stocks can make your money work for you.
Pfizer ( PFE ) Outpaces Stock Market Gains: What You Should Know
Pfizer (PFE) closed at $27.37 in the latest trading session, marking a +1.07% move from the prior day.
5 Large Cap Drug Stocks: Values or Traps?
Some drug stocks are cheap but is it another fake out?
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets - Pfizer ( NYSE:PFE )
Wall Street soared to fresh record highs at the end of the week, brushing aside the 21st U.S. government shutdown in history and a missing jobs report, as investors doubled down on bets for interest rate cuts and cheered strong gains in pharmaceutical and AI-driven tech stocks.
Why Shares of Eli Lilly Soared This Week
Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs.
MRK Stock Up Nearly 14% So Far This Week: What's Driving It?
Merck shares climb nearly 14% as Pfizer's landmark drug pricing deal with the Trump administration sparked renewed optimism in pharma stocks.
Is PFE Stock a Buy After 14% Rise Post Drug Pricing Deal With Trump?
Pfizer surges 14% after landmark Trump deal slashing drug prices while boosting U.S. investments.
Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at SITC 2025
Enara Bio to Reveal DARKFOX, a Novel Cancer-Specific Dark Antigen with Broad-Ranging Therapeutic Potential, in Oral Presentation at ...
These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True?
Dividend stocks can be great income-producing investments, but chasing high yields can sometimes leave you exposed to considerable risk.
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
You don't need to be rich to put your money to work on Wall Street.
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?
The pharma giant just eliminated two big risks.
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. - XOMA Royalty ( NASDAQ:XOMA ) , LAVA Therapeutics ( NASDAQ:LVTX )
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- XOMA Royalty Corporation ( "XOMA Royalty" ) ( NASDAQ:XOMA ) and LAVA Therapeutics N.V. ( "LAVA" ) ( NASDAQ:LVTX ) today announced the extension of the expiration of the tender offer to purchase ...
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
XOMA Royalty extends its tender offer for LAVA Therapeutics.
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
The uncertainty about U.S. pharmaceutical tariffs shouldn't be as worrisome for AstraZeneca now.
A Look Into Pfizer Inc's Price Over Earnings - Pfizer ( NYSE:PFE )
In the current market session, Pfizer Inc. ( NYSE:PFE ) share price is at $26.95, after a 0.96% drop. Over the past month, the stock spiked by 9.82%, but over the past year, it actually decreased by 5.70%.
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
Moderna plans up to 10 product launches over four years, aiming to cut reliance on fading COVID-19 vaccine sales.
Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization
CHARLOTTE, N.C., Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer ( CCO ) , effective October 6, 2025.
Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization - Dentsply Sirona ( NASDAQ:XRAY )
CHARLOTTE, N.C., Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( NASDAQ:XRAY ) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer ( CCO ) , effective October 6, 2025.
3 Things You Need to Know if You Buy Pfizer Today
Pfizer has an attractive 7.2% dividend yield, but there are some pros and cons you need to understand before you buy it.
3 Mega Dividend Stocks With Yields as High as 13.4%
These dividend stocks offer the potential to produce big-time income streams.
Government Shutdown, Government Shmutdown
Market indexes were ultimately unbothered by this latest federal government shutdown today, to say nothing of the negative private-sector payroll report this morning.
Why AbbVie Stock Cruised to an Almost 6% Gain Today
A new expansion project and a win for a peer pharmaceutical company were attracting investors to the shares.
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity.
Why Pfizer Stock Trounced the Market Today
A bullish analyst note added to the generally good sentiment on the company.
Pfizer Shares Are Trading Higher Wednesday: What's Going On? - Pfizer ( NYSE:PFE )
Pfizer ( NYSE:PFE ) shares are trading higher Wednesday after President Donald Trump announced a drug-pricing deal with the company. What To Know: Trump said Pfizer will voluntarily cut prices on many of its drugs for Medicaid patients, with discounts averaging 50% and reaching as high as 85%.
Eli Lilly Shares Are Trading Higher Wednesday: What's Going On? - Eli Lilly ( NYSE:LLY )
Eli Lilly And Company ( NYSE:LLY ) shares are trading higher Wednesday after President Donald Trump recently announced a deal with Pfizer as well as the 'TrumpRx' site to decrease prices. What To Know: Pfizer agreed to provide medicines on the TrumpRx platform at steep discounts and extend ...
Moderna Stock Is Rallying Wednesday: What's Driving The Action? - Moderna ( NASDAQ:MRNA )
Moderna Inc ( NASDAQ:MRNA ) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc ( NYSE:PFE ) and the Trump administration to lower prescription drug prices.
Why Shares in Novo Nordisk Bumped Higher Today
Pfizer's deal with the Trump administration raised hopes that the European company wouldn't be subject to 100% tariffs on certain imported drugs.
Will Pfizer Head Higher? - Pfizer ( NYSE:PFE )
Shares of Pfizer Inc. ( NYSE:PFE ) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on pharmaceuticals. This will enable Pfizer to offer its medication at significantly discounted prices ...
Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know
Pfizer's CEO says the deal with the Trump administration is "a win" for the company. He's probably right.
Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away - CVS Health ( NYSE:CVS ) , Eli Lilly ( NYSE:LLY ) , Pfizer ( NYSE:PFE ) , UnitedHealth Group ( NYSE:UNH )
Pfizer Inc's ( NYSE:PFE ) deal with Washington isn't just a handshake in the Oval Office - it's a seismic jolt to America's drug-pricing game.
Stock Market News for Oct 1, 2025
Wall Street closed higher on Tuesday, driven by healthcare stocks.
Mark Cuban Grades Trump's Online Drug Store 'B,' Plans To Give It An 'A' If These Changes Happen: 'Trump Gets All The Credit' - Pfizer ( NYSE:PFE )
Mark Cuban, the billionaire entrepreneur and investor, has given a cautious "B" grade to President Donald Trump's new online drug store venture, TrumpRx.gov. Cuban, the founder of Cost Plus Drugs, a direct-to-consumer online pharmacy, expressed his thoughts on Trump's new venture on X.
Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar deals that would make them immune to tariffs.
